IBD patients have been found to have a higher risk of lymphoma.

Published Date: 26 Apr 2023

According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.

Read Full News

Latest News

The Intersection Between Gut and Spine Health

Emerging research is showing more and more connection between the two.

IBD Flare Prediction Improved by Psychosocial Data

Predictive models that combine patient-reported psychosocial measures with clinical data perform well in forecasting flares in patients with inflammatory bowel disease.

Sacral Fracture Risk After Short-Course RT for Rectal Cancer

A recent retrospective analysis assesses the incidence and risk factors for sacral fractures among patients receiving short-course radiation therapy for rectal cancer.

Heavy Drinking Tied to Young-Onset Pancreatic Cancer

A nationwide Korean cohort study of more than 6.2 million young adults found an association between heavy alcohol use and pancreatic cancer risk before age 50.

How Gut Bacteria Could Trigger Memory Loss as We Age

Researchers found potential links between gut bacteria and memory loss, with gut-brain connections triggering loss of memory encoding in the hippocampus.

AstraZeneca's Liver Cancer Therapy Combo Slows Disease Progression in Late-stage Trial

AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant improvement in ⁠how long patients with a common liver cancer lived...

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Latest News

Emerging research is showing more and more connection between the two.

Predictive models that combine patient-reported psychosocial measures with clinical data perform well in forecasting flares in patients with inflammatory bowel disease.

A recent retrospective analysis assesses the incidence and risk factors for sacral fractures among patients receiving short-course radiation therapy for rectal cancer.

A nationwide Korean cohort study of more than 6.2 million young adults found an association between heavy alcohol use and pancreatic cancer risk before age 50.

Researchers found potential links between gut bacteria and memory loss, with gut-brain connections triggering loss of memory encoding in the hippocampus.

AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant improvement in ⁠how long patients with a common liver cancer lived...

News All Time

‘Failure to Thrive’ Now ‘Faltering Weight’ in Pediatrics

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

Tx Delays in CRC More Common in Urban Men, Racial Minorities

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

From Royal Courts to Clinics: How Enemas Evolved

Once considered a universal remedy, enemas are now used selectively for specific clinical indications, such as bowel preparation.

Popular Caraway Oil for Dyspepsia: Benefit or Risk?

Caraway oil is widely used for digestive symptoms; however, strong clinical evidence supports its use in combination with peppermint oil for functional dyspepsia.

Duchenne Gene Therapy Shows Improved Muscle Function in Trial

Regenxbio said on Wednesday that interim data from a early-to-mid stage study of its experimental gene therapy ⁠in patients with Duchenne muscular dystrophy showed continued...

Early Top-Down Therapy Cuts Surgery Risk in Crohn’s

Five-year PROFILE follow-up shows early top-down infliximab-based therapy markedly reduces abdominal surgery and hospitalizations in Crohn’s vs step-up escalation.

Commercial Microbiome Tests: Unreliable Results

Study finds major methodological differences across seven direct-to-consumer stool tests, producing taxonomic profiles as variable as those between individuals — limiting clinical use.

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

AI Beats Conventional Endoscopy in Neoplasm Detection

AI-assisted esophagogastroduodenoscopy is more effective than the conventional procedure in detecting upper GI neoplasms, particularly for lesions measuring ≤ 10 mm.

Global Study Supports Meat-Free Diets for Cancer Prevention

Observational data on more than 1.8 million people did yield surprises when it came to colorectal and esophageal cancers.

Healthy Midlife Diet Tied to Lower Risk of Cognitive Decline

Greater adherence to the DASH diet and other healthy eating patterns — especially in midlife — is linked to lower risk of cognitive decline later in life, three major US studies show.

CDC Vaccine Advisors to Consider COVID-19 Vaccine Injuries, Long COVID

The U.S. CDC's vaccine advisory committee will discuss and may vote on recommendations ⁠for issues including COVID-19 vaccine injuries and long COVID at its scheduled...

Risankizumab Effective in Crohn's, Real-World Data Show

Risankizumab is effective in inducing clinical and endoscopic remission and is generally well tolerated in patients with Crohn's disease, a real-world study shows.

Rifabutin Regimen Matches Bismuth Regimen in H pylori Rescue

Rifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.

Italian Toddler Too Sick for Second Transplant, Doctors Say

An Italian toddler left clinging to life after receiving a damaged donor heart, is not well enough to undergo a second transplant, ⁠a panel of specialists ruled on Wednesday.

Guinea-Bissau Stops Vaccine Study Funded by Trump Administration

Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving hepatitis...

Recommended News For You

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

Minimally invasive prostate cancer treatment shows success in first patient

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

CAR-T Warning for Secondary Malignancies: Warranted or Not?

Losing a reward can affect your motivation and performance.

Recommended Articles For You

Cutting-Edge Cancer Treatments: Innovations and Outcomes in Non-Hodgkin Lymphoma 

Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored 

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care 

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Have the Harms of Lung Cancer Screening Been Exaggerated?

2.

Radioactive ion beams successfully treat animal tumors in study

3.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

4.

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

5.

EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

1.

Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care

2.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

3.

Ultimate Guide to Oncology Services in the USA

4.

Unlocking the Mysteries of Synovial Sarcoma: A New Hope for Treatment

5.

Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

2.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

3.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

4.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot